For specialists

Experience of the clinical use of the local antimycotic Terbinorm spray in the practice of a dermatovenerologist
The effectiveness of methods for perioperative pain relief in patients with burns
Published in the journal «Pain, Anaesthesia and Intensive Care» № 1’2018
Changes in the functional state of the vascular endothelium, the level of C-reactive protein and cognitive functions in patients with atrial fibrillation and acute cerebrovascular accident under the influence of treatment
Published in the journal «Emergency Medicine» № 3 (98)’2019
Improving the effectiveness of treatment for patients with diabetic retinopathy
Published in the journal «Ophthalmology. Eastern Europe» Vol 9 № 2’2019
Ripronate is a new drug meldonium from a European manufacturer
Published in the weekly «Apteka» № 40 (1161)’2018
The optimal approach to the complex treatment of mixed urinary tract infections
Published in the journal «Ukrainian Journal of Dermatology, Venereology, Cosmetology» № 1 (76)’2020
Close relationship: vegetative homeostasis, biocenosis, reproductive potential
Published in the journal «Health of Ukraine» № 1 (25)’2017
Evaluation of the effectiveness of the drug Orcipol in the treatment of chronic inflammatory diseases of the male genital organs of Trichomonas - bacterial etiology
Published in a journal «Men's Health» № 4 (51)’2014
The role of combined antibacterial agents in the complex treatment of inflammatory diseases of female genital organs of mixed etiology
Published in a journal «Women's Health» № 5 (91)’2014
Modern possibilities of treatment of chronic inflammatory diseases of the genital organs in women of fertile age
Published in a journal «Women's Health» № 5 (121)’2017

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design